Terms: = Lung cancer AND APOBEC3B, ARP4, 9582, ENSG00000179750, DJ742C19_2, _phorbolin 3_, PHRBNL, FLJ21201, Q9UH17, bK150C2_2, APOBEC1L, ARCD3
111271 results:
1. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
2. Strategies to address recruitment to a randomised trial of surgical and non-surgical treatment for cancer: results from a complex recruitment intervention within the Mesothelioma and Radical Surgery 2 (MARS 2) study.
Mills N; Farrar N; Warnes B; Ashton KE; Harris R; Rogers CA; Lim E; Elliott D
BMJ Open; 2024 May; 14(5):e079108. PubMed ID: 38760029
[TBL] [Abstract] [Full Text] [Related]
3. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
Lin M; Zhao A; Chen B
Medicine (Baltimore); 2024 May; 103(20):e38204. PubMed ID: 38758858
[TBL] [Abstract] [Full Text] [Related]
4. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
[TBL] [Abstract] [Full Text] [Related]
5. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.
Yin X; Liu X; Ren F; Meng X
Cancer Immunol Immunother; 2024 May; 73(7):134. PubMed ID: 38758372
[TBL] [Abstract] [Full Text] [Related]
6. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic yield using electromagnetic navigation bronchoscopy for peripheral pulmonary nodules <2 cm.
Chen JY; Yang H; Lin XD; Yang H; Wen J; Liu QW; Zhang LJ; Lin P; Fu JH; Leng CS; Yi R; Luo KJ
Ther Adv Respir Dis; 2024; 18():17534666241249150. PubMed ID: 38757612
[TBL] [Abstract] [Full Text] [Related]
8. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
[TBL] [Abstract] [Full Text] [Related]
9. Bcl-2 dependent modulation of Hippo pathway in cancer cells.
D'Aguanno S; Brignone M; Scalera S; Chiacchiarini M; Di Martile M; Valentini E; De Nicola F; Ricci A; Pelle F; Botti C; Maugeri-Saccà M; Del Bufalo D
Cell Commun Signal; 2024 May; 22(1):277. PubMed ID: 38755629
[TBL] [Abstract] [Full Text] [Related]
10. Detection of fucosylated extracellular vesicles miR-4732-5p related to diagnosis of early lung adenocarcinoma by the electrochemical biosensor.
Zhu S; Chen J; Yu L; Li J; You S; Zheng Y; Zhuang W; Qiu B; Huang Y
Sci Rep; 2024 May; 14(1):11217. PubMed ID: 38755208
[TBL] [Abstract] [Full Text] [Related]
11. When to reinvite initially ineligible populations for targeted lung cancer screening?
Goodley P; Crosbie PAJ; Sperrin M; Merchant Z; Booton R; Balata H
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754907
[TBL] [Abstract] [Full Text] [Related]
12. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell lung cancer.
Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
[TBL] [Abstract] [Full Text] [Related]
13. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
14. Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.
Chang GC; Shih JY; Yu CJ; Chao HS; Yang CT; Lin CC; Hung JY; Hsiao SY; Wang CC; Chian CF; Hsia TC; Chen YM
PLoS One; 2024; 19(5):e0303046. PubMed ID: 38753697
[TBL] [Abstract] [Full Text] [Related]
15. Determinants and Factors of Physical Activity After Oncology Treatments (DEFACTO) in Metropolitan France: Protocol of a Mixed Methods Study and Intervention.
Aumaitre A; Gagnayre R; Foucaut AM
JMIR Res Protoc; 2024 May; 13():e52274. PubMed ID: 38753415
[TBL] [Abstract] [Full Text] [Related]
16. Patterns of distant metastasis and survival outcomes in
Liu K; Huang AL; Chen XQ; Wu SG
Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of sex inequity in lung-cancer-specific survival.
Lærum D; Strand TE; Brustugun OT; Gallefoss F; Falk R; Durheim MT; Fjellbirkeland L
Acta Oncol; 2024 May; 63():343-350. PubMed ID: 38751329
[TBL] [Abstract] [Full Text] [Related]
18. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
[TBL] [Abstract] [Full Text] [Related]
19. CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.
Yu SK; Yu T; Wang YM; Sun A; Liu J; Lu KH
J Transl Med; 2024 May; 22(1):460. PubMed ID: 38750462
[TBL] [Abstract] [Full Text] [Related]
20. Understanding the interplay of colorectal cancer awareness and attitudes among Palestinians: a national cross-sectional study.
Elshami M; Dwikat MF; Al-Slaibi I; Alser M; Albandak ME; Ayyad M; Naji SA; Mohamad BM; Isleem WS; Shurrab A; Yaghi B; Qabaja YA; Hamdan FK; Sweity RR; Jneed RT; Assaf KA; Hmaid MM; Awwad II; Alhabil BK; Alarda MN; Alsattari AS; Aboyousef MS; Aljbour OA; AlSharif R; Giacaman CT; Alnaga AY; Nemer RMA; Almadhoun NM; Skaik SM; Albarqi SI; Abu-El-Noor N; Bottcher B
BMC Cancer; 2024 May; 24(1):590. PubMed ID: 38750448
[TBL] [Abstract] [Full Text] [Related]
[Next]
